/
Milestone Scientific Inc. was incorporated in the State of Delaware in August 1989. The Company develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures.
The business is unprofitable at the operating level (-63.48% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 4.0%, steady but not accelerating.
ROIC dropped from -73.17% to -89.89%, capital efficiency is deteriorating. Negative free cash flow of -$3M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$9M
▲ +4.0% YoY
Net Income (TTM)
-$5M
▼ -21.4% YoY
Op. Margin
-50.84%
▲ +14.8pp YoY
ROIC
-99.81%
▼ -16.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
Op. Cash Flow (TTM)
-$2M
▲ +0.1% YoY
Net Debt
-$215K
Net Cash Position
Cash & Equiv.
$1M
5Y CAGR: +10.5%
Continue Research